Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
Published Works
16 September 2020
Counsel Kristin Zielinski Duggan and associate Sandra Milena McCarthy co-authored an article published by the Food and Drug Law Institute.
Published Works
12 May 2020
Life Sciences analysis: Regulation (EU) 2020/561 amends Regulation (EU) 2017/745, the Medical Devices Regulation (MDR) by postponing its application to 26 May 2021. Elisabethann Wright and...
Hogan Lovells Publications
25 March 2020
In the wake of combating the COVID-19 pandemic, the German federal government is proposing to enable further measures on a federal level. The proposal includes important measures concerning ...
Hogan Lovells Publications
22 November 2019
Digital health offers huge potential for improving care and alleviating the increasing burden on our over-stretched healthcare systems. However, its uptake remains slow and varies...
Hogan Lovells Publications
08 November 2019
Following the recent agreement to delay Brexit until 31 January 2020, the UK Department of Health and Social Care (DHSC) has written to suppliers of UK medicines and medical devices to...
News
09 September 2019
On 9 September 2019 the U.S. Food and Drug Administration (FDA or the agency) issued its final guidance document entitled Acceptance Review for De Novo Classification Requests.
Hogan Lovells Publications
16 August 2019
Device and drug manufacturers got a small surprise in the annual Physician Fee Schedule proposed rule (at 40,713-16) issued late in July by the Centers for Medicare & Medicaid Services...
News
29 May 2019
Opinion highlights importance of a "clear" record at FDA
News
17 April 2019
In our “Influencer promo guide: Best practices for drug and device firms”, we offered a list of best practices for medical device and pharmaceutical companies interested in...
